首页 | 本学科首页   官方微博 | 高级检索  
检索        

复方甘草酸苷抗乙肝病毒所致肝纤维化的临床疗效观察
引用本文:吴玮,刘春华,王千钧,王晓彬,孙树伦.复方甘草酸苷抗乙肝病毒所致肝纤维化的临床疗效观察[J].中国药房,2006,17(15):1164-1165.
作者姓名:吴玮  刘春华  王千钧  王晓彬  孙树伦
作者单位:山东青岛市传染病医院,青岛市,266033
摘    要:目的:观察复方甘草酸苷抗乙肝病毒所致肝纤维化的临床疗效。方法:将118例慢性乙肝患者随机分为A、B组,A组给予复方甘草酸苷及基础保肝药物治疗,B组仅给予基础保肝药物治疗,均治疗12wk。观察治疗前、后2组血清玻璃酸酶、层粘连蛋白、Ⅲ型前胶原肽、Ⅳ型胶原的变化。结果:治疗后A组4项指标与B组相比均明显降低,具有显著性差异(P<0·05)。结论:复方甘草酸苷是治疗乙肝病毒所致肝纤维化有效药物之一。

关 键 词:复方甘草酸苷  乙肝病毒  肝纤维化  临床疗效
文章编号:1001-0408(2006)15-1164-02
收稿时间:04 5 2006 12:00AM
修稿时间:05 10 2006 12:00AM

Clinical Efficacy of SNMC in the Treatment Hepatic Fibrosis with Hepatitis B Virus
WU Wei,LIU Chunhua,WANG Qianjun,WANG Xiaobin,SUN Shulun.Clinical Efficacy of SNMC in the Treatment Hepatic Fibrosis with Hepatitis B Virus[J].China Pharmacy,2006,17(15):1164-1165.
Authors:WU Wei  LIU Chunhua  WANG Qianjun  WANG Xiaobin  SUN Shulun
Institution:Qingdao Municipal Infectious Disease Hospital in Shangdong Province,Qingdao 266033,China
Abstract:OBJECTIVE:To study clinical efficacy of Stronger Neo-Minophagen C(SNMC)in the treatment patients with hepatic fibrosis caused by hepatitis B virus.METHODS:118chronic HB patients were divided into2groups randomly,patients in group A received SNMC and basic treatment,in group B received basic treatment,all for12weeks,4marks of hepatic fibrosis(hyaluronic acid,laminin,typeⅢprocollagen peptide,typeⅣcollagen)were determined before and after treat-ment.RESULTS:Compared with group B,4marks of hepatic fibrosis were obviously reduced in group A after treatment,which were significantly differences between2groups(P<0.05).CONCLUSIONS:SNMC may be one of clinical practical value in tr_ eatment hepatic fibrosis caused by hepatitis B virus.
Keywords:Stronger Neo - Minophagen C  Hepatitis B virus  Hepatic fibrosis  Clinical efficacy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号